Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

Women 75 and older don’t benefit from screening mammograms

Researchers analyzed Medicare claims data on more than 1 million women ages 70 to 84 to reach their conclusions.

PET, CT combine to shorten tuberculosis treatment times

"We hope that the tool will one day enable clinicians to determine the most effective doses of specific drugs in specific patients, so as to further optimize the treatment of infectious diseases," investigators of the new trial wrote in Nature Medicine.

Thumbnail

CT detects coronavirus abnormalities before symptoms appear, reveals new clinical finding

The study details the first case of associated bilateral pleural effusions in an individual with lab-confirmed COVID-19.

Thumbnail

MRI predicts ‘frozen shoulder’ in rotator cuff tears

Two imaging findings—specifically, joint capsule swelling and thickness at the recess of the armpit—are useful to predict shoulder stiffness in patients with this particular injury.

Thumbnail

Chest CT yields higher sensitivity than lab testing standard for diagnosing coronavirus

Chinese researchers published a new case set of 51 patients with confirmed COVID-19, and found chest CT's sensitivity was much greater than real-time polymerase chain reaction lab testing.

Thumbnail

Digital PET detects smaller cancerous lesions, produces images nuclear medicine experts prefer

Providers believe the digital modality could ultimately provide a more accurate cancer diagnosis compared to conventional PET, authors reported in the Journal of Nuclear Medicine.

Thumbnail

NorthStar’s new FDA approval means ‘immediate increase’ in Mo-99 production

The U.S Food and Drug Administration gave the go-ahead for two additional molybdenum-99 filling lines at the company's Columbia, Missouri, facility.

Thumbnail

FDA approves International Isotopes’ I-131 therapeutic agent

Idaho-based International Isotopes has received U.S. Food and Drug Administration approval for its radioactive therapeutic agent used to treat thyroid cancers.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.